The Cxbladder Rule-Out of Recurrent Urothelial Carcinoma
common.study.values.description
“The Cxbladder Rule-out of Recurrent Urothelial Carcinoma”
This observational study is designed to collect urine and relevant clinical information from patients who have a known diagnosis of bladder cancer and currently on clinically driven surveillance. The study aims to compare the urine test to the flexible cystoscopy procedure (which the patient is already scheduled).
common.study.values.location
participant.ui.study.affiliations-map.online-study.header-virtual
participant.ui.study.affiliations-map.online-study.text
common.study.values.methods
common.study.methods.has-drugs-no
common.study.methods.is-healthy-yes
Diagnostic Test - Cx bladder Monitor test
Cxbladder Monitor is a non-invasive UC detection test measuring five messenger RNA (mRNA) biomarkers present at elevated levels in patients presenting with urothelial carcinoma and also two clinical variables (whether the previous tumor was primary or recurrent and the time since the previous tumor was resected).
participant.views.study.view.additional
participant.views.study.view.scientific-title
A Clinical, Non-intervention Study of the Cxbladder Urine Test for the Detection of Recurrent Urinary Tract Urothelial Carcinoma
common.study.values.clinical-trial-id
NCT03673202
participant.views.study.view.id
e1w6Pb
